Cargando…

Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I

The monkeypox outbreak has become a global public health emergency. The lack of valid and safe medicine is a crucial obstacle hindering the extermination of orthopoxvirus infections. The identification of potential inhibitors from natural products, including Traditional Chinese Medicine (TCM), by mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaopeng, An, Sanqi, Chu, Jiemei, Liang, Bingyu, Liao, Yanyan, Jiang, Junjun, Lin, Yao, Ye, Li, Liang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919579/
https://www.ncbi.nlm.nih.gov/pubmed/36771105
http://dx.doi.org/10.3390/molecules28031444
_version_ 1784886857563111424
author Hu, Xiaopeng
An, Sanqi
Chu, Jiemei
Liang, Bingyu
Liao, Yanyan
Jiang, Junjun
Lin, Yao
Ye, Li
Liang, Hao
author_facet Hu, Xiaopeng
An, Sanqi
Chu, Jiemei
Liang, Bingyu
Liao, Yanyan
Jiang, Junjun
Lin, Yao
Ye, Li
Liang, Hao
author_sort Hu, Xiaopeng
collection PubMed
description The monkeypox outbreak has become a global public health emergency. The lack of valid and safe medicine is a crucial obstacle hindering the extermination of orthopoxvirus infections. The identification of potential inhibitors from natural products, including Traditional Chinese Medicine (TCM), by molecular modeling could expand the arsenal of antiviral chemotherapeutic agents. Monkeypox DNA topoisomerase I (TOP1) is a highly conserved viral DNA repair enzyme with a small size and low homology to human proteins. The protein model of viral DNA TOP1 was obtained by homology modeling. The reliability of the TOP1 model was validated by analyzing its Ramachandran plot and by determining the compatibility of the 3D model with its sequence using the Verify 3D and PROCHECK services. In order to identify potential inhibitors of TOP1, an integrated library of 4103 natural products was screened via Glide docking. Surface Plasmon Resonance (SPR) was further implemented to assay the complex binding affinity. Molecular dynamics simulations (100 ns) were combined with molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) computations to reveal the binding mechanisms of the complex. As a result, three natural compounds were highlighted as potential inhibitors via docking-based virtual screening. Rosmarinic acid, myricitrin, quercitrin, and ofloxacin can bind TOP1 with KD values of 2.16 μM, 3.54 μM, 4.77 μM, and 5.46 μM, respectively, indicating a good inhibitory effect against MPXV. The MM/PBSA calculations revealed that rosmarinic acid had the lowest binding free energy at −16.18 kcal/mol. Myricitrin had a binding free energy of −13.87 kcal/mol, quercitrin had a binding free energy of −9.40 kcal/mol, and ofloxacin had a binding free energy of −9.64 kcal/mol. The outputs (RMSD/RMSF/Rg/SASA) also indicated that the systems were well-behaved towards the complex. The selected compounds formed several key hydrogen bonds with TOP1 residues (TYR274, LYS167, GLY132, LYS133, etc.) via the binding mode analysis. TYR274 was predicted to be a pivotal residue for compound interactions in the binding pocket of TOP1. The results of the enrichment analyses illustrated the potential pharmacological networks of rosmarinic acid. The molecular modeling approach may be acceptable for the identification and design of novel poxvirus inhibitors; however, further studies are warranted to evaluate their therapeutic potential.
format Online
Article
Text
id pubmed-9919579
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99195792023-02-12 Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I Hu, Xiaopeng An, Sanqi Chu, Jiemei Liang, Bingyu Liao, Yanyan Jiang, Junjun Lin, Yao Ye, Li Liang, Hao Molecules Article The monkeypox outbreak has become a global public health emergency. The lack of valid and safe medicine is a crucial obstacle hindering the extermination of orthopoxvirus infections. The identification of potential inhibitors from natural products, including Traditional Chinese Medicine (TCM), by molecular modeling could expand the arsenal of antiviral chemotherapeutic agents. Monkeypox DNA topoisomerase I (TOP1) is a highly conserved viral DNA repair enzyme with a small size and low homology to human proteins. The protein model of viral DNA TOP1 was obtained by homology modeling. The reliability of the TOP1 model was validated by analyzing its Ramachandran plot and by determining the compatibility of the 3D model with its sequence using the Verify 3D and PROCHECK services. In order to identify potential inhibitors of TOP1, an integrated library of 4103 natural products was screened via Glide docking. Surface Plasmon Resonance (SPR) was further implemented to assay the complex binding affinity. Molecular dynamics simulations (100 ns) were combined with molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) computations to reveal the binding mechanisms of the complex. As a result, three natural compounds were highlighted as potential inhibitors via docking-based virtual screening. Rosmarinic acid, myricitrin, quercitrin, and ofloxacin can bind TOP1 with KD values of 2.16 μM, 3.54 μM, 4.77 μM, and 5.46 μM, respectively, indicating a good inhibitory effect against MPXV. The MM/PBSA calculations revealed that rosmarinic acid had the lowest binding free energy at −16.18 kcal/mol. Myricitrin had a binding free energy of −13.87 kcal/mol, quercitrin had a binding free energy of −9.40 kcal/mol, and ofloxacin had a binding free energy of −9.64 kcal/mol. The outputs (RMSD/RMSF/Rg/SASA) also indicated that the systems were well-behaved towards the complex. The selected compounds formed several key hydrogen bonds with TOP1 residues (TYR274, LYS167, GLY132, LYS133, etc.) via the binding mode analysis. TYR274 was predicted to be a pivotal residue for compound interactions in the binding pocket of TOP1. The results of the enrichment analyses illustrated the potential pharmacological networks of rosmarinic acid. The molecular modeling approach may be acceptable for the identification and design of novel poxvirus inhibitors; however, further studies are warranted to evaluate their therapeutic potential. MDPI 2023-02-02 /pmc/articles/PMC9919579/ /pubmed/36771105 http://dx.doi.org/10.3390/molecules28031444 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hu, Xiaopeng
An, Sanqi
Chu, Jiemei
Liang, Bingyu
Liao, Yanyan
Jiang, Junjun
Lin, Yao
Ye, Li
Liang, Hao
Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I
title Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I
title_full Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I
title_fullStr Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I
title_full_unstemmed Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I
title_short Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I
title_sort potential inhibitors of monkeypox virus revealed by molecular modeling approach to viral dna topoisomerase i
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919579/
https://www.ncbi.nlm.nih.gov/pubmed/36771105
http://dx.doi.org/10.3390/molecules28031444
work_keys_str_mv AT huxiaopeng potentialinhibitorsofmonkeypoxvirusrevealedbymolecularmodelingapproachtoviraldnatopoisomerasei
AT ansanqi potentialinhibitorsofmonkeypoxvirusrevealedbymolecularmodelingapproachtoviraldnatopoisomerasei
AT chujiemei potentialinhibitorsofmonkeypoxvirusrevealedbymolecularmodelingapproachtoviraldnatopoisomerasei
AT liangbingyu potentialinhibitorsofmonkeypoxvirusrevealedbymolecularmodelingapproachtoviraldnatopoisomerasei
AT liaoyanyan potentialinhibitorsofmonkeypoxvirusrevealedbymolecularmodelingapproachtoviraldnatopoisomerasei
AT jiangjunjun potentialinhibitorsofmonkeypoxvirusrevealedbymolecularmodelingapproachtoviraldnatopoisomerasei
AT linyao potentialinhibitorsofmonkeypoxvirusrevealedbymolecularmodelingapproachtoviraldnatopoisomerasei
AT yeli potentialinhibitorsofmonkeypoxvirusrevealedbymolecularmodelingapproachtoviraldnatopoisomerasei
AT lianghao potentialinhibitorsofmonkeypoxvirusrevealedbymolecularmodelingapproachtoviraldnatopoisomerasei